Addus HomeCare (ADUS) director awarded 1,449 restricted shares vesting in 2027

Rhea-AI Filing Summary

Addus HomeCare Corp director Darin J. Gordon received 1,449 shares of common stock as a restricted stock grant. The award carries no cash exercise price and increases his direct holdings to 14,244 shares. The restricted shares were granted as compensation for non-employee director service and will vest in full on June 10, 2027.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Gordon Darin J.

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,449	$0.00	--

Holdings After Transaction: Common Stock — 14,244 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Restricted shares granted: 1,449 shares Price per share: $0.0000 per share Shares held after grant: 14,244 shares +1 more

4 metrics

Restricted shares granted 1,449 shares Common Stock award on June 10, 2026

Price per share $0.0000 per share Grant/award acquisition, non-derivative

Shares held after grant 14,244 shares Total direct holdings following transaction

Vesting date June 10, 2027 Restricted shares vest in full on this date

Key Terms

Restricted shares, non-employee directors, Grant, award, or other acquisition, Form 4

4 terms

Restricted shares financial

"Restricted shares granted to non-employee directors that will vest in full on June 10, 2027."

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

non-employee directors financial

"Restricted shares granted to non-employee directors that will vest in full on June 10, 2027."

Non-employee directors are board members who do not work for the company as salaried employees and usually do not hold day-to-day management roles. They act like outside referees or independent coaches, providing oversight, asking tough questions, and protecting shareholders’ interests; investors care because these directors help ensure management is accountable, reduce conflicts of interest, and influence decisions that affect company strategy and long-term value.

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/11/2026 - 04:31 PM Accepted by SEC EDGAR 06/11/2026 - 04:31 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gordon Darin J.

(Last) (First) (Middle)

6303 COWBOYS WAY

SUITE 600

(Street)

FRISCO TEXAS 75034

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Addus HomeCare Corp [ ADUS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/10/2026		A		1,449(1)	A	$0	14,244	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted shares granted to non-employee directors that will vest in full on June 10, 2027.

	/s/ Brian Poff, Attorney-In-Fact for Darin J. Gordon	06/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Addus HomeCare (ADUS) report for Darin J. Gordon?

Addus HomeCare reported that director Darin J. Gordon received a grant of 1,449 shares of common stock. These are restricted shares awarded as a non-employee director grant, recorded with no cash purchase price in the Form 4 filing.

How many Addus HomeCare (ADUS) shares does Darin J. Gordon hold after this grant?

After the restricted stock grant, Darin J. Gordon directly holds 14,244 shares of Addus HomeCare common stock. This total reflects his position immediately following the June 10, 2026 non-derivative award reported in the Form 4.

What type of shares did the Addus HomeCare (ADUS) director receive?

The director received restricted shares of common stock in Addus HomeCare. These shares are subject to vesting conditions and were granted as a non-employee director award rather than purchased in the open market.

When do Darin J. Gordon’s restricted Addus HomeCare (ADUS) shares vest?

The restricted shares granted to Darin J. Gordon will vest in full on June 10, 2027. Until that vesting date, the award remains subject to the company’s restricted stock conditions described in the Form 4 footnote.

Was there a purchase price for the Addus HomeCare (ADUS) director’s new shares?

The Form 4 lists a transaction price per share of $0.0000 for the 1,449 restricted shares. This indicates the shares were issued as a compensation grant rather than bought in a cash transaction on the open market.